title: N-acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes.
abstract: N-Acetylaspartylglutamate (NAAG) is the most prevalent peptide in the mammalian nervous system. NAAG meets the traditional criteria of a neurotransmitter, including localization in synaptic vesicles, depolarization-induced release, low potency activation of some N-methyl-D-aspartate receptors, and highly selective activation of a cAMP-coupled metabotropic glutamate receptor (mGluR) with potency approaching that of glutamate. The peptide is present in cultured cortical glia in high concentration and is hydrolyzed by cell surface peptidase activity. In the present work, we tested the hypothesis that NAAG selectively activates a subclass of metabotropic receptors on cultured rat cerebellar glia, primarily astrocytes. These glial cells express mRNA for mGluR subtypes 1, 3, 4, 5, 6, 7, and 8. We were not able to detect message for mGluR2 in these cells using the reverse transcriptase-polymerase chain reaction. Cerebellar glia responded to NAAG, glutamate, and trans-ACPD with a decrease in forskolin-stimulated cAMP formation. AP4, an agonist of the group III receptors mGluR4, mGluR6, mGluR7, and mGluR8, had little or no effect on stimulated cAMP levels. Treatment with low micromolar NAAG significantly increased uptake of radioactive thymidine by cultured astrocytes through activation of metabotropic glutamate receptors. Antagonists of group II mGluRs prevented the decrease in cAMP and the increase in uptake of thymidine by NAAG. Cultured cerebellar astrocytes expressed 20 pmol NAAG per mg protein, a value that is at least 30-fold lower than that expressed by mixed glial cultures prepared from mouse cortex. We conclude that cerebellar astrocytes respond to NAAG via the mGluR3 receptor and that the peptide may selectively activate this receptor subtype in astrocytes following release from neurons or glia.
authors.affiliation: Department of Biology, Georgetown University, Washington, DC 20057-1229, USA.
authors.forename: B
authors.initials: B
authors.lastname: Wroblewska
authors.forename: M R
authors.initials: MR
authors.lastname: Santi
authors.forename: J H
authors.initials: JH
authors.lastname: Neale
mesh_terms: D000818:Animals; D001253:Astrocytes / Q000378:metabolism*; D002268:Carboxypeptidases / Q000378:metabolism; D002478:Cells, Cultured; D002531:Cerebellum / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D000242:Cyclic AMP / Q000502:physiology*; D004151:Dipeptides / Q000494:pharmacology*; D043425:Glutamate Carboxypeptidase II; D007150:Immunohistochemistry; D018696:Neuroprotective Agents / Q000494:pharmacology*; D015345:Oligonucleotide Probes; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D051381:Rats; D018094:Receptors, Metabotropic Glutamate / Q000187:drug effects*; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D004151:Dipeptides; D018696:Neuroprotective Agents; D015345:Oligonucleotide Probes; D012333:RNA, Messenger; D018094:Receptors, Metabotropic Glutamate; C027172:isospaglumic acid; D000242:Cyclic AMP; D002268:Carboxypeptidases; D043425:Glutamate Carboxypeptidase II